Navigation Links
Skin-disease patients show brain immunity to faces of disgust
Date:8/27/2009

People with psoriasis an often distressing dermatological condition that causes lesions and red scaly patches on the skin are less likely to react to looks of disgust by others than people without the condition, new research has found.

University of Manchester scientists used magnetic resonance imaging (MRI) scans to compare the brains of 26 men, half of whom had chronic psoriasis. The researchers looked at the insular cortex a part of the brain triggered by both feelings and observations of disgust to see how participants responded to images of disgusted faces.

The study, published in the Journal of Investigative Dermatology, found that the volunteers with psoriasis had a much weaker response in their insular cortex than the healthy volunteers, suggesting they have developed a coping mechanism to protect themselves from adverse emotional responses to their condition by others.

"Psoriasis has a significant negative impact on the physical and psychological well-being of those affected but little is known about the neurocognitive mechanisms of how patients cope with the adverse social stigma associated with visible skin lesions," said Dr Elise Kleyn, the dermatologist who carried out the research.

"We had previously shown that psoriasis patients commonly believe that they will be evaluated solely on the basis of their skin and so often avoid social situations they think will be stressful or humiliating as a coping mechanism.

"For this study we wanted to investigate whether the social impact of psoriasis is associated with altered cognitive processing in response to facial expressions of disgust by measuring brain activity in the insular cortex.

"We found a significantly reduced response in the insular cortex in the patients compared with the control volunteers when observing disgusted faces, but also that patients were half as likely to recognise that a face was expressing disgust. This was not the
'/>"/>

Contact: Aeron Haworth
aeron.haworth@manchester.ac.uk
44-161-275-8383
University of Manchester
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
2. Comparison of obstetric outcomes between on-call and patients own obstetricians
3. Vision restoration therapy shown to improve brain activity in brain injured patients
4. Diabetes appears to increase risk of death for patients with acute coronary syndromes
5. Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia
6. Restricting Blood Flow May Help Heart Bypass Patients
7. Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer
8. Study provides hope that some transplant patients could live free of antirejection drugs
9. Study provides hope that some transplant patients could live free of anti-rejection drugs
10. Longer ambulance journeys boost death risk for seriously ill patients
11. Expenses Overshadow Optimism for Kidney Failure Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... November 21, 2014 Body Well Therapy, a ... it accepts Spafinder massage gift cards and ... hotel massage in all service areas including throughout Florida and ... to go to the spa at all to redeem your ... of Body Well. "We may not be able to transport ...
(Date:11/21/2014)... The cost of diabetes care in the United States ... more than $322 billion annually, a new report shows. ... prediabetes care, which have risen 74 percent, and undiagnosed ... In 2012, excess medical costs and lost productivity ... American. That total includes $244 billion in medical costs ...
(Date:11/21/2014)... they,ve mapped the genome -- the genetic "blueprint" -- of ... it might help others with this very rare infection. ... , the tapeworm was removed from the brain of a ... so rare worldwide and completely unexpected in this country that ... pulled out from the brain," study lead author Hayley Bennett, ...
(Date:11/21/2014)... 21, 2014 MLF Biotech, Inc. has ... . Liv-Pro® Probiotics for Pets helps maintain digestive health ... a pet's intestinal flora after it experiences a period ... Liv-Pro Probiotics for Pets is a proprietary blend of ... seven live active bacteria strains that are safe and ...
(Date:11/21/2014)... 21, 2014 Saint Luke’s Mid ... The Guidelines®–Heart Failure Gold-Plus Quality Achievement Award for ... American Heart Association/American College of Cardiology Foundation in ... , Get With The Guidelines–Heart Failure is a ... the most up-to-date, research-based guidelines with the goal ...
Breaking Medicine News(10 mins):Health News:Body Well Mobile Massage Announces Acceptance of Spafinder Gift Cards for In Home Massage, Hotel Massage for Travelers 2Health News:Cost of Diabetes Care Keeps Climbing, Report Shows 2Health News:Ick! Tapeworm Infecting Man's Brain Yields Genetic Secrets 2Health News:MLF Biotech Introduces Liv-Pro Probiotics for Pets 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 4
... March 7 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ... webcast live during the Cowen & Company 28th ... 8:00 a.m. Eastern Time., The presentation will ... access the live presentation via the Web, please ...
... Affiliated Computer Services,Inc. (NYSE: ACS ) today ... to provide electronic health records and pharmacy,benefits management solutions. ... years,and a total value of $57 million if all ... will provide the state with several components,of ACS, electronic ...
... March 6 Nfocus Neuromedical, Inc.,announced today that ... StarFire Medical is a manufacturer of therapeutic implantable ... The assets acquired include products such as ... Silicone Balloon), also,known as the Endeavor Balloon Catheter, ...
... Webcast Scheduled for March 7, 2008 at 2:00 pm ... Ensign,Group, Inc. (Nasdaq: ENSG ), the parent company ... and assisted living,companies, today reported results for the fourth ... (Logo: http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO ), Highlights ...
... 6 QED International Associates, Inc.,administrator for the ... the HealthShares(TM) Exchange-Traded Funds, today announced,that effective at ... ISIS,Pharmaceuticals (Nasdaq: ISIS ) will replace Pharmion ... Index. Synta Pharmaceuticals Corp.,(Nasdaq: SNTA ) will ...
... A new study suggests that a type of acute ... one small molecule result in the over-activity of genes important ... myeloid leukemia (AML) and a gene mutation called NPM1, an ... The findings suggest new therapeutic targets for treating the disease ...
Cached Medicine News:Health News:Alexza's Corporate Presentation to be Webcast at the Cowen & Company 28th Annual Health Care Conference 2Health News:ACS Announces $57 Million Contract With Missouri HealthNet 2Health News:ACS Announces $57 Million Contract With Missouri HealthNet 3Health News:Nfocus Neuromedical Announces Acquisition of StarFire Medical 2Health News:The Ensign Group, Inc. Reports Fourth Quarter 2007 Earnings 2Health News:The Ensign Group, Inc. Reports Fourth Quarter 2007 Earnings 3Health News:The Ensign Group, Inc. Reports Fourth Quarter 2007 Earnings 4Health News:The Ensign Group, Inc. Reports Fourth Quarter 2007 Earnings 5Health News:The Ensign Group, Inc. Reports Fourth Quarter 2007 Earnings 6Health News:The Ensign Group, Inc. Reports Fourth Quarter 2007 Earnings 7Health News:The Ensign Group, Inc. Reports Fourth Quarter 2007 Earnings 8Health News:QED International Associates Announces Changes to the HealthShares(TM) Composite and HealthShares(TM) Cancer Indexes 2Health News:Low micro-RNA level linked to high gene activity in AML 2
(Date:11/21/2014)... 2014  Edwards Lifesciences Corporation (NYSE: EW ... valves and hemodynamic monitoring, announced today that it will ... a strong launch of Edwards Lifesciences Foundation,s new charitable ... the global communities where its employees live and work. ... will exceed $8 million, including more than $7 million ...
(Date:11/21/2014)... /CNW Telbec/ - KLOX Technologies Inc. ("KLOX" or the ... Todd Martensen has been hired ... of Chief Commercial Officer, to oversee KLOX,s commercial launch ... for the treatment of chronic and other hard-to-heal wounds, ... in Europe . Mr. Martensen, a ...
(Date:11/21/2014)... GABLES, Fla. , Nov. 20, 2014   ... to become the first U.S. commercial producer of Molybdenum-99 ... a contract with INVAP to design its ... Fla. Mo-99 is the parent isotope of ... medicine procedures worldwide. In 2012, Congress passed legislation making ...
Breaking Medicine Technology:Edwards Lifesciences Increases Charitable Giving In 2014 To Support Launch Of Every Heartbeat Matters 2KLOX Technologies announces executive appointments 2KLOX Technologies announces executive appointments 3KLOX Technologies announces executive appointments 4Coqui RadioPharmaceuticals Inks Deal With INVAP 2
... Cell Therapeutics, Inc. (CTI),(Nasdaq and MTA: CTIC) today announced that the following presentations,will ... formerly XYOTAX(TM)),at the 44th American Society of Clinical Oncology (ASCO) Annual Meeting,May 30 through ... Poster # ... (Abstract#) Sat., ...
... First and Only Treatment for Hunter Syndrome Now Approved in ... ... Worldwide, BASINGSTOKE, England and CAMBRIDGE, Massachusetts, May ... company, announced that ELAPRASE(R),(idursulfase), a human enzyme replacement therapy for ...
Cached Medicine Technology:Cell Therapeutics, Inc. (CTI) Announces Presentations at American Society of Clinical Oncology (ASCO) Annual Meeting 2Cell Therapeutics, Inc. (CTI) Announces Presentations at American Society of Clinical Oncology (ASCO) Annual Meeting 3Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 2Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 3Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 4Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 5
... surgery, and the accompanying need for patient ... graft be developed. Grafts must not only ... available in varying sizes and configurations for ... long been the prosthetic of choice among ...
... GORE-TEX Vascular Grafts have met the challenges ... over 25 years. Recognized for exceptional performance ... of renowned surgeons worldwide. These grafts require ... of infection, and assure utmost thrombectomy safety. ...
... Vascular Grafts have met the challenges of ... 25 years. Recognized for exceptional performance and ... renowned surgeons worldwide. These grafts require no ... infection, and assure utmost thrombectomy safety. Gore ...
... Graft, the newest vascular graft offering from ... in vascular surgical products for more than ... kinking and compression problems that can ... provides all of the benefits of a ...
Medicine Products: